Clinical Trial

Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease

Study acronym: REAL-SMART
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate long-term safety and performance per the intended use of the S.M.A.R.T.™ Nitinol Stent System (SMART 120/150), S.M.A.R.T.™ CONTROL™ Nitinol Stent System (SMART CONTROL) and S.M.A.R.T.™ Flex Vascular Stent System (SMART Flex) in the treatment of iliac and femoropopliteal artery disease.
Trial Details
NCT Number NCT07338890
Lead Sponsor Cordis US Corp.
Collaborators: Rede Optimus Hospitalar SA
Conditions Superficial Femoral Artery Stenosis, Iliac Artery Stenosis, Popliteal Artery Stenosis
Enrollment 240 participants
Start Date 2026-01-31
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-14